LeukemiaRemission InductionLeukemia, Myeloid, AcuteRemission, SpontaneousLeukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidLeukemia, ExperimentalLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia Virus, MurineCytarabineLeukemia, T-CellLeukemia, Monocytic, AcuteLeukemia, Hairy CellRecurrenceMoloney murine leukemia virusTreatment OutcomeLeukemia, B-CellLeukemia L1210Leukemia Virus, BovineLeukemia Virus, FelineAntineoplastic Combined Chemotherapy ProtocolsDaunorubicinGene Expression Regulation, LeukemicAcute DiseaseBone MarrowLeukemia, Radiation-InducedMyeloid-Lymphoid Leukemia ProteinAntineoplastic AgentsPrognosisLeukemia, Biphenotypic, AcuteVincristineLeukemia P388Bone Marrow TransplantationCyclophosphamideFusion Proteins, bcr-ablLeukemia-Lymphoma, Adult T-CellNeoplasm, ResidualAsparaginaseFriend murine leukemia virusMethotrexateHL-60 CellsPrednisoneLeukemia, Megakaryoblastic, AcuteCombined Modality TherapyPrecursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, Chronic-PhaseDisease-Free SurvivalKaryotypingFollow-Up StudiesTransplantation, HomologousIdarubicinHematopoietic Stem Cell TransplantationTransplantation, AutologousTime FactorsAKR murine leukemia virusSurvival Analysis6-MercaptopurinePhiladelphia ChromosomeLymphomaPrednisoloneLeukemia, Plasma CellThioguanineLeukemia, Myeloid, Accelerated PhaseVidarabineSurvival RateTumor Cells, CulturedLeukemia, Prolymphocytic, T-CellEtoposideAntibodies, MonoclonalOxidesLeukemic InfiltrationCladribineNeoplasm ProteinsK562 CellsDrug Administration ScheduleGraft vs Leukemia EffectLeukemia, ProlymphocyticCytogenetic AnalysisDoxorubicinfms-Like Tyrosine Kinase 3ArsenicalsRetrospective StudiesImmunophenotypingLymphoma, Non-HodgkinChromosome AberrationsCore Binding Factor Alpha 2 SubunitLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeCell LineAntibodies, Monoclonal, Murine-DerivedDrug Resistance, NeoplasmSalvage TherapyPrecursor T-Cell Lymphoblastic Leukemia-LymphomaHuman T-lymphotropic virus 1TretinoinBase SequenceGene RearrangementImmunosuppressive AgentsFlow CytometryGraft vs Host Disease